🇺🇸 Beta blocker in United States
609 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 609
Most-reported reactions
- Completed Suicide — 152 reports (24.96%)
- Death — 63 reports (10.34%)
- Nausea — 63 reports (10.34%)
- Dyspnoea — 61 reports (10.02%)
- Dizziness — 54 reports (8.87%)
- Fatigue — 46 reports (7.55%)
- Drug Ineffective — 45 reports (7.39%)
- Hypotension — 44 reports (7.22%)
- Cardiac Arrest — 42 reports (6.9%)
- Atrial Fibrillation — 39 reports (6.4%)
Other Cardiovascular approved in United States
Frequently asked questions
Is Beta blocker approved in United States?
Beta blocker does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Beta blocker in United States?
Spanish Society of Cardiology is the originator. The local marketing authorisation holder may differ — check the official source linked above.